ADURO BIOTECH INC's ticker is ADRO and the CUSIP is 00739L101. A total of 93 filers reported holding ADURO BIOTECH INC in Q1 2018. The put-call ratio across all filers is 0.64 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $808,000 | +3572.7% | 349,677 | +1617.8% | 0.00% | – |
| Q3 2019 | $22,000 | -70.7% | 20,356 | -58.4% | 0.00% | – |
| Q2 2019 | $75,000 | -14.8% | 48,923 | +121.5% | 0.00% | – |
| Q1 2019 | $88,000 | +137.8% | 22,090 | +58.9% | 0.00% | – |
| Q4 2018 | $37,000 | -86.4% | 13,902 | -62.5% | 0.00% | – |
| Q3 2018 | $272,000 | +1.9% | 37,037 | -2.8% | 0.00% | – |
| Q2 2018 | $267,000 | -52.8% | 38,093 | -37.4% | 0.00% | -100.0% |
| Q1 2018 | $566,000 | +106.6% | 60,896 | +66.9% | 0.00% | – |
| Q4 2017 | $274,000 | -3.9% | 36,497 | +36.5% | 0.00% | – |
| Q3 2017 | $285,000 | -11.2% | 26,732 | -4.9% | 0.00% | – |
| Q2 2017 | $321,000 | +93.4% | 28,123 | +82.3% | 0.00% | – |
| Q1 2017 | $166,000 | +9.2% | 15,424 | +15.9% | 0.00% | – |
| Q4 2016 | $152,000 | -29.3% | 13,305 | -23.3% | 0.00% | – |
| Q3 2016 | $215,000 | +50.3% | 17,336 | +37.1% | 0.00% | – |
| Q2 2016 | $143,000 | – | 12,642 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HARVARD MANAGEMENT CO INC | 640,595 | $4,708,000 | 1.20% |
| BVF INC/IL | 287,776 | $2,115,000 | 0.19% |
| ORACLE INVESTMENT MANAGEMENT INC | 111,542 | $820,000 | 0.18% |
| Sofinnova Investments, Inc. | 189,579 | $1,393,000 | 0.12% |
| CENTAURUS FINANCIAL, INC. | 85 | $624,000 | 0.11% |
| Artal Group S.A. | 550,000 | $4,043,000 | 0.10% |
| Vident Investment Advisory, LLC | 305,311 | $2,244,000 | 0.09% |
| Virtus ETF Advisers LLC | 61,463 | $452,000 | 0.05% |
| Foundry Partners, LLC | 106,907 | $786,000 | 0.03% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 239,301 | $1,759,000 | 0.02% |